GO:0036211 | protein modification process | 20.31% (26/128) | 2.28 | 0.0 | 0.0 |
GO:0006464 | cellular protein modification process | 20.31% (26/128) | 2.28 | 0.0 | 0.0 |
GO:0043412 | macromolecule modification | 20.31% (26/128) | 2.2 | 0.0 | 0.0 |
GO:0006796 | phosphate-containing compound metabolic process | 19.53% (25/128) | 2.11 | 0.0 | 0.0 |
GO:0006793 | phosphorus metabolic process | 19.53% (25/128) | 2.11 | 0.0 | 0.0 |
GO:0004672 | protein kinase activity | 16.41% (21/128) | 2.35 | 0.0 | 0.0 |
GO:0006468 | protein phosphorylation | 16.41% (21/128) | 2.36 | 0.0 | 0.0 |
GO:0044267 | cellular protein metabolic process | 20.31% (26/128) | 2.06 | 0.0 | 0.0 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 16.41% (21/128) | 2.27 | 0.0 | 0.0 |
GO:0016310 | phosphorylation | 16.41% (21/128) | 2.28 | 0.0 | 0.0 |
GO:0016301 | kinase activity | 16.41% (21/128) | 2.25 | 0.0 | 0.0 |
GO:0016740 | transferase activity | 21.09% (27/128) | 1.83 | 0.0 | 0.0 |
GO:0019538 | protein metabolic process | 20.31% (26/128) | 1.83 | 0.0 | 0.0 |
GO:0044260 | cellular macromolecule metabolic process | 20.31% (26/128) | 1.79 | 0.0 | 0.0 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 16.41% (21/128) | 2.06 | 0.0 | 0.0 |
GO:0003824 | catalytic activity | 33.59% (43/128) | 1.16 | 0.0 | 2e-06 |
GO:0009987 | cellular process | 27.34% (35/128) | 1.32 | 0.0 | 2e-06 |
GO:1901564 | organonitrogen compound metabolic process | 20.31% (26/128) | 1.58 | 0.0 | 4e-06 |
GO:0140096 | catalytic activity, acting on a protein | 16.41% (21/128) | 1.76 | 1e-06 | 1e-05 |
GO:0043170 | macromolecule metabolic process | 21.09% (27/128) | 1.47 | 1e-06 | 1e-05 |
GO:0006807 | nitrogen compound metabolic process | 23.44% (30/128) | 1.35 | 1e-06 | 1.3e-05 |
GO:0044237 | cellular metabolic process | 23.44% (30/128) | 1.32 | 2e-06 | 1.9e-05 |
GO:0044238 | primary metabolic process | 24.22% (31/128) | 1.26 | 3e-06 | 2.6e-05 |
GO:0007165 | signal transduction | 7.03% (9/128) | 2.91 | 3e-06 | 2.7e-05 |
GO:0071704 | organic substance metabolic process | 24.22% (31/128) | 1.2 | 7e-06 | 5.5e-05 |
GO:0008150 | biological_process | 33.59% (43/128) | 0.9 | 1.5e-05 | 0.000116 |
GO:0050794 | regulation of cellular process | 8.59% (11/128) | 2.13 | 4.6e-05 | 0.000342 |
GO:0050789 | regulation of biological process | 8.59% (11/128) | 2.1 | 5.5e-05 | 0.000394 |
GO:0003674 | molecular_function | 43.75% (56/128) | 0.66 | 6.2e-05 | 0.00042 |
GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity | 3.12% (4/128) | 4.21 | 6.1e-05 | 0.000427 |
GO:0005524 | ATP binding | 13.28% (17/128) | 1.53 | 8e-05 | 0.000487 |
GO:0004112 | cyclic-nucleotide phosphodiesterase activity | 3.12% (4/128) | 4.11 | 7.9e-05 | 0.000502 |
GO:0032559 | adenyl ribonucleotide binding | 13.28% (17/128) | 1.52 | 8.5e-05 | 0.000502 |
GO:0030554 | adenyl nucleotide binding | 13.28% (17/128) | 1.52 | 8.8e-05 | 0.00051 |
GO:0065007 | biological regulation | 8.59% (11/128) | 2.04 | 7.9e-05 | 0.000515 |
GO:0008152 | metabolic process | 25.78% (33/128) | 0.95 | 0.000117 | 0.000636 |
GO:0035639 | purine ribonucleoside triphosphate binding | 14.06% (18/128) | 1.43 | 0.000115 | 0.000645 |
GO:0032555 | purine ribonucleotide binding | 14.06% (18/128) | 1.43 | 0.000121 | 0.000645 |
GO:0017076 | purine nucleotide binding | 14.06% (18/128) | 1.42 | 0.000126 | 0.000655 |
GO:0000166 | nucleotide binding | 14.84% (19/128) | 1.36 | 0.000136 | 0.000671 |
GO:1901265 | nucleoside phosphate binding | 14.84% (19/128) | 1.36 | 0.000136 | 0.000671 |
GO:0032553 | ribonucleotide binding | 14.06% (18/128) | 1.41 | 0.000141 | 0.000676 |
GO:0008144 | drug binding | 13.28% (17/128) | 1.45 | 0.000159 | 0.000697 |
GO:0043167 | ion binding | 17.97% (23/128) | 1.19 | 0.000154 | 0.000705 |
GO:0097367 | carbohydrate derivative binding | 14.06% (18/128) | 1.4 | 0.00015 | 0.000706 |
GO:0043168 | anion binding | 14.84% (19/128) | 1.35 | 0.000158 | 0.00071 |
GO:0036094 | small molecule binding | 14.84% (19/128) | 1.29 | 0.000257 | 0.001103 |
GO:0008081 | phosphoric diester hydrolase activity | 3.12% (4/128) | 3.66 | 0.000281 | 0.001181 |
GO:0042578 | phosphoric ester hydrolase activity | 3.12% (4/128) | 2.77 | 0.002802 | 0.011551 |
GO:0043413 | macromolecule glycosylation | 2.34% (3/128) | 2.97 | 0.006608 | 0.026171 |
GO:0006486 | protein glycosylation | 2.34% (3/128) | 2.97 | 0.006608 | 0.026171 |
GO:0070085 | glycosylation | 2.34% (3/128) | 2.94 | 0.00696 | 0.027037 |
GO:0000159 | protein phosphatase type 2A complex | 0.78% (1/128) | 7.11 | 0.007215 | 0.027498 |
GO:0097159 | organic cyclic compound binding | 16.41% (21/128) | 0.81 | 0.007671 | 0.028174 |
GO:1901363 | heterocyclic compound binding | 16.41% (21/128) | 0.81 | 0.007671 | 0.028174 |
GO:0009187 | cyclic nucleotide metabolic process | 3.12% (4/128) | 2.29 | 0.009093 | 0.032224 |
GO:0009190 | cyclic nucleotide biosynthetic process | 3.12% (4/128) | 2.29 | 0.009093 | 0.032224 |
GO:0016849 | phosphorus-oxygen lyase activity | 3.12% (4/128) | 2.28 | 0.009372 | 0.032641 |
GO:0035556 | intracellular signal transduction | 3.12% (4/128) | 2.11 | 0.013878 | 0.047515 |
GO:1903293 | phosphatase complex | 0.78% (1/128) | 6.11 | 0.014378 | 0.047613 |
GO:0008287 | protein serine/threonine phosphatase complex | 0.78% (1/128) | 6.11 | 0.014378 | 0.047613 |